Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
- 1 May 1999
- journal article
- research article
- Published by Springer Nature in Nature Cell Biology
- Vol. 1 (1) , 60-67
- https://doi.org/10.1038/9035
Abstract
Indirubin is the active ingredient of Danggui Longhui Wan, a mixture of plants that is used in traditional Chinese medicine to treat chronic diseases. Here we identify indirubin and its analogues as potent inhibitors of cyclin-dependent kinases (CDKs). The crystal structure of CDK2 in complex with indirubin derivatives shows that indirubin interacts with the kinase’s ATP-binding site through van der Waals interactions and three hydrogen bonds. Indirubin-3′-monoxime inhibits the proliferation of a large range of cells, mainly through arresting the cells in the G2/M phase of the cell cycle. These results have implications for therapeutic optimization of indigoids.Keywords
This publication has 18 references indexed in Scilit:
- CYCLIN-DEPENDENT KINASES: Engines, Clocks, and MicroprocessorsAnnual Review of Cell and Developmental Biology, 1997
- Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin‐Dependent Kinases cdc2, cdk2 and cdk5European Journal of Biochemistry, 1997
- Structural basis of cyclin-dependent kinase activation by phosphorylationNature Structural & Molecular Biology, 1996
- The Synthesis, Antileukemic Activity, and Crystal Structures of Indirubin DerivativesBulletin of the Chemical Society of Japan, 1996
- Multiple modes of ligand recognition: Crystal structures of cyclin‐dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenineProteins-Structure Function and Bioinformatics, 1995
- Traditional Chinese herbal medicinePharmacy World & Science, 1995
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D-Biological Crystallography, 1994
- Highlight on the studies of anticancer drugs derived from plants in chinaThe International Journal of Cell Cloning, 1994
- Crystal structure of cyclin-dependent kinase 2Nature, 1993
- Structure of a Peptide Inhibitor Bound to the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein KinaseScience, 1991